Revenio Group Oyj · OMXHEX:REG1V
Revenio Group Oyj — Q4 2020 Earnings Presentation
13 slides from Revenio Group Oyj's earnings presentation, Feb 11, 2021
Slide 1: Despite the exceptional circumstances, 2020 ended with very strong net sales growth
Despite the exceptional circumstances, 2020 ended with very strong net sales and operating profit growth 11.2.2021 CEO Jouni Toijala CFO Robin Pulkkinen 1
Slide 2: Business Summary of 2020
Business Summary of 2020 CEO Jouni Toijala CFO Robin Pulkkinen 2
Slide 3: Effects of the Covid-19 pandemic
Effects of the Covid-19 pandemic The risks and uncertainties related to the global Covid-19 pandemic grew significantly during the first quarter of 2020. During the second quarter of 2020, a gradual market reopening could already be observed around the world. Towards the end of the year, the uncerta
Slide 4: October – December 2020 Main Points
October – December 2020 MAIN POINTS Positive profit warning for July-December regarding net sales growth was an indication of the N ET SAL ES 19.7 MEUR organization's excellent ability to adapt quickly to the changed situation The strong development of the business was due +31.7% YoY to the incr
Slide 5: January – December 2020 Main Points
January – December 2020 MAIN POINTS N ET SAL ES 61.1 MEUR Sales in the United Stated grew strongly during 2020. Demand was particularly strong for iCare intraocular pressure measurement devices and their single-use +23.4% YoY probes. Sales were also boosted by some unusually large orders Sales o
Slide 6: Key Financials of 2020
Key Financials of 2020 Key Figures MEUR 1.1.-31.12.2020 1.1.-31.12.2019 Change % 1.10.-31.12.2020 1.10.-31.12.2019 Change % Net sales 61,1 49,5 23,4 % 19,7 14,9 31,7 % EBIT 17,1 12,6 36,0 % 7,6 5,2 46,2 % EBIT % 28,1 % 25,5 % 2,6 % 38,8 % 34,9 % 3,8 % Adjusted EBIT *** 19,1 15,4 24,2 % 7,6 5,2 46,2
Slide 7: Development of key figures
Development of key figures - Towards the end of the year, 100,0% the uncertainty caused by 81,6% 84,0% 81,8% the Covid-19 pandemic 78,9% 80,0% again increased and the 66,1% 62,4% 60,9% pandemic continues to 58,6% 60,0% cause uncertainty related to 40,0% 31,6% 35,5% 33,3% 31,0% 31,2% the markets also
Slide 8: Shareholders and share
Shareholders and share ~~ REVENIO
Slide 9: Ownership 31.12.2020
Ownership 31.12.2020 # Owners Capital Country 1 William Demant Invest A/S 10,88 % Denmark 2 SEB Funds 4,68 % Sweden 3 Columbia Threadneedle 4,24 % United States 4 Capital Group 2,97 % United States 5 Ilmarinen Mutual Pension Insurance Company 2,50 % Finland 6 Groupama Asset Management 2,43 % France
Slide 10: Share price development
Share price development 2020-01 2020-03 2020-05 2020-07 2020-09 2020-11 REVENIO
Slide 11: Financial guidance for 2021
Financial quidance for 2021 Covid-19 pandemic continues to cause uncertainty related to the markets. Revenio Group’s exchange rate-adjusted net sales are estimated to grow strongly from the previous year and profitability is to remain at a good level without non-recurring items. 11
Slide 12: Board's Proposal to the Annual General Meeting
Board’s Proposal to the Annual General Meeting D I V I D EN D P RO P OSAL E UR 0 . 3 2 (0 . 3 0 ) The Board of Directors will propose to the Annual General Meeting on March 17, 2021 that a per- share dividend of EUR 0.32 (0.30) to be paid. The remainder of the distributable earnings will be retained
Slide 13: THANK YOU!
THANK YOU! QUEST IO NS ? 13